Eric D. Donnenfeld, MD, FAAO - ASCRS 2019

Eric Donnenfeld, MD - Omidria trialПодробнее

Eric Donnenfeld, MD - Accomodating IOLsПодробнее

Interview: Eric Donnefield at the Ophthalmology Innovation Summit @ASCRS 2012Подробнее

Dr. Eric D. Donnenfeld Interview - EyePointPharma.comПодробнее

Topical anti-integrin therapyПодробнее

Eric Donnenfeld, MD: Effect of Omidria on pain and opioid usage during cataract surgeryПодробнее

Dr. Eric DonnenfeldПодробнее

Hawaiian Eye 2019 - Eric Donnenfeld, MDПодробнее

My Journey in Partnering With Industry and the Impact on Ophthalmology - Eric Donnenfeld (ASCRS)Подробнее

Eric Donnenfeld, MD with OCLI VISION recognized as 2022 Newsweek #1 Ophthalmologist in AmericaПодробнее

Avenova and TearScience Sponsor ASCRS 2017 Round Table – Saponification and Lid HygieneПодробнее

Beyond Glasses: Dr. Eric Donnenfeld on Next-Gen Intraocular Lenses from OCLI VISIONПодробнее

Eric Donnenfeld, MD reflects on how COVID has changed practices and sees eye care demand growing.Подробнее

Voted Newsweek #1 Eye Doctor in America, Eric Donnenfeld, MD talks about who gets the credit.Подробнее

Revolutionizing LASIK: Dr. Eric Donnenfeld on Today's Advancements from OCLI VISION, NYПодробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ ASRS 2019Подробнее

2019 Twin Cities OSD Symposium. Dr. Donnenfeld. Surgical care of OSD refractory to other treatments.Подробнее

A conversation with Dr. Eric DonnenfeldПодробнее